Prospective Evaluation of Rate of Fusion with Augment Injectable Bone Graft
Category: Hindfoot; Basic Sciences/Biologics Introduction/Purpose: Augment ® Bone Graft is a mixture of rhPDGF-BB, beta-TCP and bovine collagen which has received FDA approval for use as a substitute for autografts during hindfoot and/or ankle arthrodesis. Although a recent meta analysis demonstrate...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-12-01
|
Series: | Foot & Ankle Orthopaedics |
Online Access: | https://doi.org/10.1177/2473011423S00387 |